US 8501930
Peptide-based in vivo siRNA delivery system
granted A61KA61K47/549A61K47/64
Quick answer
US patent 8501930 (Peptide-based in vivo siRNA delivery system) held by Arrowhead Madison, Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Madison, Inc.
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/549, A61K47/64, A61K47/6415, A61P